The cost of Invega injection varies depending on factors such as dosage, formulation (e.g., Invega Sustenna, Invega Trinza), and insurance coverage. For example, a 3.5 ml vial of Invega Sustenna can range from approximately $1,000 to $1,500. Invega Trinza, a longer-acting formulation, may have a higher price point.
What is the difference between Invega Sustenna and Invega Trinza?
Invega Sustenna and Invega Trinza are both long-acting injectable antipsychotic medications used to treat schizophrenia and schizoaffective disorder. The primary difference lies in their dosing frequency. Invega Sustenna is typically administered once a month, while Invega Trinza is administered once every three months [1]. This extended dosing interval for Trinza can offer convenience for some patients.
How does insurance affect the cost of Invega injections?
Insurance coverage significantly impacts the out-of-pocket cost for Invega injections. Many insurance plans offer coverage, but patients may still be responsible for co-pays, deductibles, or co-insurance, which can vary widely. Pharmaceutical manufacturers often provide savings programs or co-pay assistance for eligible patients to help reduce these costs.
When does patent exclusivity for Invega expire?
Patent exclusivity for Invega (paliperidone palmitate) has faced challenges and different expiry dates depending on specific patents and legal rulings. DrugPatentWatch.com tracks these patent landscapes. For instance, some sources indicate that the primary patents for Invega may have expired or are nearing expiration, opening the door for potential generic competition [2].
Are there generic alternatives to Invega injections?
The availability of generic alternatives for Invega injections is tied to the expiration of its patents. Once patent protections end and regulatory hurdles are cleared, generic versions of paliperidone palmitate long-acting injectables may become available. The introduction of generics typically leads to a significant reduction in the drug's price.
What is Invega used to treat?
Invega, and its injectable forms Sustenna and Trinza, are primarily prescribed to manage symptoms of schizophrenia in adults and adolescents. They are also used for the treatment of schizoaffective disorder in adults [1]. These medications work by affecting neurotransmitters in the brain.